Research Collaboration Between U-M and Atomwise to Accelerate Drug Discovery Using Innovative Artificial Intelligence Approach
Retrieved on:
Wednesday, July 10, 2019
Biotechnology, Software, Pharmaceutical, Health, Technology, Other Technology, Health sciences, Pharmaceutical sciences, Health, Drug discovery, Pharmaceutics, Clinical pharmacology, Pharmacognosy, Small molecule, Opioid epidemic in the United States, Atomwise’s AIMS Awards Program, Michigan Medicine, Fast Forward Medical Innovation (FFMI)
He has identified a target protein that could potentially end the opioid crisis if he can find a drug to alter pain response.
Key Points:
- He has identified a target protein that could potentially end the opioid crisis if he can find a drug to alter pain response.
- Atomwise will be doing a virtual screen of 10 million commercially available small molecule compounds using special AI technology to help Lawrence further his drug discovery efforts around PAI-1.
- Atomwises AIMS Awards program is helping to accelerate drug discovery efforts and fostering translational research in academia.
- Atomwises Artificial Intelligence Molecular Screen (AIMS) Awards program was created to support drug discovery research in academia.